SEC Form 4 · accession 0001655016-26-000004
Edgewise Therapeutics, Inc. · EWTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan C Fox
Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 1, 2026 · 7:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001710072
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | A | 319 | $0.00 | A | 24,833 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Consists of restricted stock units granted and released to the reporting person on July 1, 2026, as a Quarterly Retainer Award pursuant to Section 2.4 of the Edgewise Therapeutics, Inc. Outside Directors Compensation Policy, as amended.